E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer

被引：0
|
作者：
Taofeek K. Owonikoko
Joseph Aisner
Xin Victoria Wang
Suzanne E. Dahlberg
Eric H. Rubin
Suresh S. Ramalingam
Murugesan Gounder
Paul Gregory Rausch
Rita S. Axelrod
Joan H. Schiller
机构：
[1] Emory University,Department of Biostatistics
[2] Rutgers Cancer Institute of New Jersey,Department of Biostatistics
[3] Harvard School of Public Health,undefined
[4] Dana–Farber Cancer Institute,undefined
[5] Merck Research Laboratories,undefined
[6] Frederick Memorial Hospital,undefined
[7] Thomas Jefferson University,undefined
[8] University of Texas Southwestern Medical Center,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 73卷
关键词：
Small cell; Topoisomerase; Clinical trial; Topotecan; Irinotecan; Sequential administration; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：171 / 180
页数：9
相关论文
共 50 条
  • [1] E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer
    Owonikoko, Taofeek K.
    Aisner, Joseph
    Wang, Xin Victoria
    Dahlberg, Suzanne E.
    Rubin, Eric H.
    Ramalingam, Suresh S.
    Gounder, Murugesan
    Rausch, Paul Gregory
    Axelrod, Rita S.
    Schiller, Joan H.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (01) : 171 - 180
  • [2] Phase II study of cisplatin/etoposide and endostar for extensive-stage small-cell lung cancer
    Zhou, Zheng-tao
    Zhou, Fu-xiang
    Wei, Qing
    Zou, Li-yong
    Qin, Bin-fang
    Peng, Xu-shen
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (04) : 1027 - 1032
  • [3] Cisplatin Combined with Irinotecan or Etoposide for Untreated Extensive-Stage Small Cell Lung Cancer
    Shi, Yuankai
    Hu, Xingsheng
    Hu, Yi
    Han, Xiaohong
    Li, Xue
    Lin, Lin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S625 - S625
  • [4] Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung cancer
    Xiao, Xiaoguang
    Wang, Shujing
    Xia, Shu
    Zou, Man
    Li, Yang
    Wei, Yao
    Mei, Qi
    Chen, Yuan
    ONCOTARGETS AND THERAPY, 2015, 8 : 2209 - 2214
  • [5] Combination Chemotherapy of Alternating Etoposide and Carboplatin with Weekly Administration of Irinotecan and Cisplatin in Extensive-stage Small-cell Lung Cancer
    Yoshimura, Akinobu
    Noro, Rintaro
    Miyanaga, Akihiko
    Mizutani, Hideaki
    Kosaihira, Seiji
    Minegishi, Yuji
    Seike, Masahiro
    Hino, Mitsunori
    Ando, Masahiro
    Nomura, Koichiro
    Okano, Tetsuya
    Kobayashi, Kunihiko
    Gemma, Akihiko
    ANTICANCER RESEARCH, 2012, 32 (10) : 4473 - 4478
  • [6] Cisplatin, etoposide, and irinotecan for relapsed small-cell lung cancer
    Qin, Angel
    Kalemkerian, Gregory P.
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S1142 - S1144
  • [7] Cisplatin-etoposide alternating with topotecan in patients with extensive stage small cell lung cancer (SCLC) - A multicenter phase II study
    Mavroudis, D
    Veslemes, M
    Kouroussis, C
    Tzanakis, N
    Ferdoutsis, E
    Toumbis, M
    Ziotopoulos, P
    Agelidou, M
    Tselepatiotis, E
    Kalbakis, K
    Souglakos, J
    Magkanas, E
    Samonis, G
    Georgoulias, V
    LUNG CANCER, 2002, 38 (01) : 59 - 63
  • [8] Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer
    E. Briasoulis
    E. Samantas
    H. Kalofonos
    D. Skarlos
    T. Makatsoris
    C. Christodoulou
    G. Fountzilas
    A. Bamias
    M.A. Dimopoulos
    P. Kosmidis
    N. Pavlidis
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 521 - 528
  • [9] Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer
    Briasoulis, E
    Samantas, E
    Kalofonos, H
    Skarlos, D
    Makatsoris, T
    Christodoulou, C
    Fountzilas, G
    Bamias, A
    Dimopoulos, MA
    Kosmidis, P
    Pavlidis, N
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (05) : 521 - 528
  • [10] Irinotecan plus cisplatin compared with etoposide plus cisplatin in patients with previously untreated extensive-stage small cell lung cancer: A meta-analysis
    Liu, Zi-Li
    Wang, Bin
    Liu, Ji-Zhu
    Liu, Wei-Wei
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 : S1076 - S1083
12345